PDE5A and ocular hypertension: We previously showed that tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, increased cGMP levels and prevented age-related degeneration of RGCs in GC1−/− mice and in the microbead occlusion model of ocular hypertension [9].